David McManus to Cardiovascular Agents
This is a "connection" page, showing publications David McManus has written about Cardiovascular Agents.
Connection Strength
0.624
-
McManus DD, Saczynski JS, Lessard D, Kinno M, Pidikiti R, Esa N, Harrington J, Goldberg RJ. Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study). Am J Cardiol. 2013 May 15; 111(10):1460-5.
Score: 0.390
-
Tran HV, Waring ME, McManus DD, Erskine N, Do VTH, Kiefe CI, Goldberg RJ. Underuse of Effective Cardiac Medications Among Women, Middle-Aged Adults, and Racial/Ethnic Minorities With Coronary Artery Disease (from the National Health and Nutrition Examination Survey 2005 to 2014). Am J Cardiol. 2017 Oct 15; 120(8):1223-1229.
Score: 0.130
-
Barringhaus KG, Park KL, McManus DD, Steg PG, Montalescot G, Van de Werf F, L?pez-Send?n J, FitzGerald G, Gore JM. Outcomes from patients with multi-vessel disease following primary PCI: staged PCI imparts very low mortality. Catheter Cardiovasc Interv. 2011 Apr 01; 77(5):617-22.
Score: 0.084
-
Santolucito PA, Tighe DA, McManus DD, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Management and outcomes of renal disease and acute myocardial infarction. Am J Med. 2010 Sep; 123(9):847-55.
Score: 0.020